论文部分内容阅读
巴西国家卫生监管部门Anvisa不满知识产权保护阻碍了农药登记进程。与近年来的新产品批准过程相比,非专利产品的批准明显快很多。自2002
Anvisa, Brazil’s national health regulator, dissatisfied with intellectual property rights blocking the pesticide registration process. Compared with the new product approval process in recent years, the approval of generic products is significantly faster. Since 2002